| Literature DB >> 34927468 |
Gustav Ø Andersen1, Stefan Milosevic1, Mads M Jensen1, Mikkel Ø Andersen2, Ane Simony2, Mikkel M Rasmussen1, Leah Carreon2,3.
Abstract
STUDYEntities:
Keywords: chronic pain; coccyx; injection; orthopedic
Year: 2021 PMID: 34927468 PMCID: PMC9393997 DOI: 10.1177/21925682211065389
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Prisma Flowchart.
Studies Included for Analysis in Systematic Review.
| Author(s), year | Study Type | Eligible Patients/Total Patients | Intervention Category | Extracted Outcome | Length of Follow-Up (mos.) | Strengthening the Reporting of Observational Studies in Epidemiology—Score |
|---|---|---|---|---|---|---|
| Abdel-Aal et al.
| RCT | 60 | Conservative/ Usual care | VAS, MMST, ODI | 1 | - |
| Adas et al.
| Retrospective cohort study | 36/41 | RFT | VAS, QA | 6 | 18 |
| Alvik and Helsingen.
| Retrospective cohort study | 13/17 | Coccygectomy | QA, Comp | 65 | 7 |
| Antoniadis et al.
| Retrospective cohort study | 10 | Coccygectomy | VAS, QA, Comp | 12 | 17 |
| Awwad et al.
| Retrospective cohort study | 8/70 | Coccygectomy | QA, Comp | 72 | 10 |
| Bayne et al.
| Retrospective cohort study | 34/48 | Coccygectomy | QA, Comp | 83 | 11 |
| Bilgic et al.
| Retrospective cohort study | 25 | Coccygectomy | VAS, QA, Comp | 21 | 17 |
| Bohm.
| Retrospective cohort study | 14 | Rhizotomy | QA, Comp | 45 | 3 |
| Cebesoy et al.
| Retrospective cohort study | 21 | Coccygectomy | VAS, QA | 26 | 14 |
| Chen et al.
| Retrospective cohort study | 12 | RFT | QA, Comp | 6 | 13 |
| Cheng et al.
| Retrospective cohort study | 31 | Coccygectomy | QA, Comp | 40 | 9 |
| Cortiñas Sáenz et al.
| Retrospective cohort study | 21 | Ganglion block | VAS, QA | 6 | 16 |
| Dalbayrak et al, 2014 | Retrospective cohort study | 32 | Coccygectomy, injection | VAS, Comp | N/A | 9 |
| Datir and connell.
| Retrospective cohort study | 8 | Ganglion block | VAS, QA | 6 | 10 |
| Demircay et al.
| Retrospective cohort study | 10 | RFT | VNS, EQ-5D | 9 | 16 |
| Doursounian et al.
| Retrospective cohort study | 61 | Coccygectomy | QA, Comp | 6 | 11 |
| Doursounian et al.
| Retrospective cohort study | 136 | Coccygectomy | Comp | N/A | 16 |
| Doursounian et al.
| Retrospective cohort study | 33 | Coccygectomy | Paris questionnaire, QA, Comp | >24 | 16 |
| El Mohsen Arafa et al.
| Prospective cohort study | 38 | Coccygectomy | VAS, QA, Comp | 48 | 15 |
| Feldbrin et al.
| Retrospective cohort study | 7/9 | Coccygectomy | QA | >12 | 13 |
| Finsen.
| Retrospective cohort study | 11 | Injection | QA | 64 | 10 |
| Galhom et al.
| Retrospective cohort study | 50 | Conservative/ Usual care, injection, coccygectomy | QA, Comp | 17 | 14 |
| Gáspár et al.
| Retrospective cohort study | 32/34 | Coccygectomy | VAS, QA | 91 | 15 |
| Gonen Aydin et al.
| Retrospective cohort study | 34 | ESWT | VAS, SF-36, QA | 6 | 15 |
| Gonnade et al.
| Prospective cohort study | 31 | Ganglion block | NRS, ODI, QA | 6 | 18 |
| Gopal and McCrory
| Retrospective cohort study | 20 | RFT | VAS, QA | 12 | 12 |
| Gunduz et al.
| Retrospective pilot study | 22 | Ganglion block | VAS, QA | 3 wks | 15 |
| Haddad et al.
| Retrospective cohort study | 14 | Coccygectomy | PAS, QA, Comp | 80 | 15 |
| Haghighat and Mashayekhi asl
| Quasi-experimental study | 10 | ESWT | VAS | 7 | 18 |
| Hanley et al.
| Prospective cohort study | 98 | Coccygectomy | VAS, ODI, SF-36, QA, Comp | 24 | 22 |
| Hodges et al.
| Retrospective cohort study | 11/32 | Coccygectomy | VAS, ODI, QA, Comp | >9 | 15 |
| Karalezli et al.
| Retrospective cohort study | 14 | Coccygectomy | QA, Comp | 30 | 9 |
| Karaman et al.
| Retrospective cohort study | 8/24 | RFT | VAS, QA | 9 | 17 |
| Kerr et al.
| Retrospective cohort study | 23/26 | Coccygectomy | VAS, QA, Comp | 37 | 17 |
| Khan et al.
| Prospective cohort study | 37 | Prolotherapy | VAS, Comp | N/A | 11 |
| Kircelli et al.
| Retrospective cohort study | 20 | RFT | VNS, EQ-5D, QA | 17 | 16 |
| Kleimeyer et al.
| Retrospective cohort study | 88 | Coccygectomy, conservative/ Usual care | VAS, EQ-5D, PROMIS, QA, Comp. | 58 | 17 |
| Kulkarni et al.
| Retrospective cohort study | 10 | Coccygectomy | VAS, QA, Comp | 21 | 14 |
| Lin et al.
| RCT | 41 | ESWT, interferential current | VAS, ODI, SSS | 2 | - |
| Maigne et al.
| Prospective cohort study | 37 | Coccygectomy | QA, Comp | >24 | 15 |
| Maigne and Chatellier
| Prospective pilot study | 74 | Stretching/Manipulation | VAS, QA | 24 | 21 |
| Maigne et al.
| RCT | 102 | Conservative/Usual care, stretching/Manipulation | VAS, McGill, Paris and Dallas questionnaires, QA | 6 | - |
| Margo
| Retrospective cohort study | 13/318 | Coccygectomy | QA | - | 7 |
| Marwan et al.
| Prospective cohort study | 14/17 | ESWT | NPS, ODI | 4 | 18 |
| Mohanty and Pattnaik
| Experimental study | 48 | Conservative/Usual care, stretching/Manipulation, Injection | QA | 1 | 16 |
| Mouhsine et al.
| Retrospective cohort study | 15 | Coccygectomy | QA, Comp | 32 | 13 |
| Ogur et al.
| Retrospective cohort study | 22 | Coccygectomy | VAS, QA, Comp | 28 | 15 |
| Perkins et al.
| Retrospective cohort study | 13 | Coccygectomy | NPS, ODI, QA, Comp | 43 | 13 |
| Pyper
| Retrospective cohort study | 28 | Coccygectomy | QA, Comp | 42 | 8 |
| Ramsey et al.
| Retrospective cohort study | 15/24 | Coccygectomy | QA, Comp | 14 | 9 |
| Rubio et al.
| Prospective cohort study | 6 | Ganglion block | QA, Comp | - | 12 |
| Sarmast et al.
| Prospective cohort study | 16 | Coccygectomy | VAS, QA, Comp | 24 | 14 |
| Sehirlioglu et al.
| Retrospective cohort study | 74 | Coccygectomy | QA, Comp | 49 | 13 |
| Seker et al.
| Retrospective cohort study | 44 | Injection | VAS, QA | 28 | 16 |
| Sencan et al.
| Retrospective cohort study | 37 | Ganglion block | VAS, QA, Comp | 5 | 18 |
| Sencan et al.
| RCT | 73 | Ganglion block | NRS, Beck test | 3 | - |
| Sir and Eksert.
| Retrospective cohort study | 39 | Ganglion block, injection | NPRS, Likert scale, Comp | 6 | 17 |
| Sucuoglu et al.
| Prospective cohort study | 8/128 | Injection | VAS | 3 wks | 18 |
| Traub et al.
| Retrospective cohort study | 8/10 | Coccygectomy | Comp | 22 | 12 |
| Trollegaard et al.
| Retrospective cohort study | 41 | Coccygectomy | QA, Comp | 83 | 16 |
| Wood and Mehbod
| Retrospective cohort study | 45 | Coccygectomy, injectionSSS | QA, Comp | 26 | 14 |
| Wright
| Prospective cohort study | 12 | Chemical ablation | QA | >12 | 7 |
| Yeganeh et al.
| RCT | 61 | Injection | VAS | 2 | - |
Abbreviations: RCT, Randomized Controlled Trial; VAS, Visual Analog Scale; MMST, Modified Modified Schober Test; ODI, Oswestry Disability Index; RFT, Radiofrequency thermocoagulation; QA, Qualitative Assessment; Comp, Complications; VNS, Visual Numeric Scale; EQ-5D, EuroQoL-5 Domain; ESWT, Extracorporeal Shockwave Therapy; SF-36, Short Form 36; NRS, Numeric Rating Scale; PAS, Pain Analogue Score; VNS, Visual Numeric Scale; PROMIS, Patient-Reported Outcomes Measurement Information System; SSS, Subjective Satisfaction Score; NPS, Numeric Pain Scale; NPRS, Numeric Pain Rating Scale.
Summary of Pooled Data Available for Extraction from Included Studies by Type of Intervention.
| Coccygectomy | Conservative/Usual care | Extracorporeal Shockwave Therapy | Injection | Radiofrequency therapy | Stretching/Manipulation | Ganglion block | Coccygectomy + DaneSpine | |
|---|---|---|---|---|---|---|---|---|
| Patients (N) | 991 | 157 | 78 | 174 | 120 | 125 | 223 | 1103 |
| Females (%) | 81% | 71% | 79% | 77% | 65% | 90% | 78% | 82% |
| Age, yrs, mean | 42.20 | 46.90 | 40.71 | 34.82 | 48.20 | 45.18 | 41.18 | 42.01 |
| Symptom duration, mos, mean | 21.87 |
| 27.70 | 5.47 | 24.21 |
| 16.75 | 21.87 |
| Length of follow-up, mos, mean | 29.79 | 49.54 | 5.43 | 25.29 | 6.58 |
| 5.49 | 27.71 |
| BMI, kg/m2, mean | 25.98 | 28.47 | 25.54 |
| 24.24 | 27.09 | 26.26 | |
| Pain score, 0–10, mean | ||||||||
| Baseline | 7.54 | 6.69 | 8.13 | 5.56 | 7.52 | 6.24 | 7.92 | 7.44 |
| 2–6 wks | 4.98 | 3.17 | 4.18 | 2.83 |
| 3,27 | ||
| 8–16 wks |
| 2.80 |
|
| 3.97 |
| ||
| 6 mos | 2.96 | 3.07 | 2.92 | 4.94 | 2.96 | |||
| ≥ 12 mos | 2.32 |
| 1.34 | 2.41 | 2.58 | |||
| Evaluation of outcome | ||||||||
| Successful (%) | 85% | 31% | 79% | 53% | 82% | 24% | 75% | 83.4% |
| Moderate (%) | 4% | 0% | 0% | 0% | 2% | 0% | 2% | 5.6% |
| Poor (%) | 11% | 69% | 21% | 47% | 16% | 76% | 24% | 11% |
| Complications (%) | 11% | 8% | 0% | 1% | 12.5% | |||
| Evaluation of outcome | ||||||||
| Successful (N) | 697/817 | 32/104 | 27/34 | 60/113 | 79/96 | 30/124 | 89/119 | 775/929 |
| Moderate (N) | 32/817 | 0/104 | 0/34 | 0/113 | 2/96 | 0/124 | 2/119 | 52/929 |
| Poor (N) | 88/817 | 72/104 | 7/34 | 53/113 | 15/96 | 94/124 | 28/119 | 102/929 |
| Complications (N) | 104/918 | 2/26 | 1/68 | 128/1026 | ||||
Abbreviation: BMI, Body Mass Index.
Summarized analysis of change in VAS-scores pre- and post- Intervention by type of Intervention. Follow-up score used only if data is from more than one study.
| Baseline | Follow-Up | Difference | |
|---|---|---|---|
| Coccygectomy | 7.54 | 2.32 | 5.22 |
| Coccygectomy + dane | 7.44 | 2.58 | 4.86 |
| Spine | |||
| Conservative/Usual care | 6.69 | 4.98 | 1.71 |
| Extracorporeal shockwave therapy | 8.13 | 3.07 | 5.06 |
| Injection | 5.56 | 1.34 | 4.22 |
| Radiofrequency therapy | 7.52 | 2.41 | 5.11 |
| Stretching/Manipulation | 6.24 | 2.19 | |
| Ganglion block | 7.92 | 4.94 | 2.98 |
Figure 2.Change in NRS-scores Pre- and Post-Intervention by Type of intervention. Abbreviations: RFT, Radiofrequency thermocoagulation; ESWT, Extracorporeal Shock Wave Therapy.